ReWalk Robotics places their 500th exoskeleton system

Meant for those with spinal cord injuries, ReWalk was the first exoskeleton to be cleared by the FDA for sale in the United States in June 2014.

0 November 12, 2018
Devin Jones

ReWalk ReWalk Robotics Ltd. recently announced that the company has placed its 500th robotic exoskeleton medical device. The majority of these devices are personal systems used by individuals with spinal cord injury in their homes and communities, while others are located in rehabilitation centers to evaluate and train potential device owners.

The first ReWalk device was placed in 2011 to the Vatican Hospital in Rome, and it became the first exoskeleton to be cleared by the FDA for sale in the United States in June 2014. To continue its growth, the Company is focused on expanding insurance coverage of exoskeletons for all persons with spinal cord injury and has helped develop national coverage policies with payers in several countries, including Germany, Italy and the U.S. Department of Veterans Affairs.

The Company continues to work with payers on individual system procurements as well as the development of broad private coverage policies and additional national coverage policies for eligible beneficiaries. To date, 38 different payers in the United States and 39 in Germany have provided positive coverage decisions for ReWalk Personal systems to their clients.

“500 units placed is an important moment in our mission to improve the quality of life for individuals with lower limb disability,” said ReWalk CEO Larry Jasinski. “Most of all, we see this moment as a chance to reflect on the myriad lives that have been impacted by the technology.

www.ReWalk.com 


Leave a Reply

Your email address will not be published. Required fields are marked *

*